Clarus Builds Investment Team

Feb 10 2006 | 10:18pm ET

Clarus Ventures, a global life sciences venture capital firm with offices in San Francisco and Cambridge, Mass., has filled out its investment team to manage its first fund, which closed in December with $500 million in committed capital. The firm has hired three principals and a controller to help manage the fund and Robert Liptak, managing director, said the firm is looking to make one additional hire.

The newly-formed team includes Emmett Cunningham, Michele Park and Scott Requadt, who have joined the firm as principals, and Danielle Bechard, who has joined as controller.

Prior to joining the firm's San Francisco office, Cunningham was senior vice president of medical strategy at Eyetech Pharmaceuticals, where he played a leadership role in the development and approval of Macugen, a drug used to help age-related macular degeneration.

Park joins the San Francisco office of Clarus from Credit Suisse First Boston, where she was an analyst covering large, medium and small capitalization biotechnology companies with a focus on companies with oncologic and anti-infective products.

Requadt joins the Cambridge office from TransForm Pharmaceuticals, where he was director of business development.

Finally, Bechard joins the Cambridge office from the McDonald's Corporation, where she was responsible for franchisee analysis.

The fund will invest in predominantly later-stage biotechnology firms, Liptak said.


In Depth

Fitch Says Alternative Asset Managers 'Stable' Despite Dry Powder

Nov 20 2014 | 9:30am ET

Ratings agency Fitch says the outlook for seven publicly traded alternative asset...

Lifestyle

Cohen Buys $101 Million Sculpture

Nov 12 2014 | 9:17am ET

Steven Cohen was the sole bidder for a rare Alberto Giacometti sculpture at Sotheby...

Guest Contributor

Why The Big Money Is Going To Europe

Nov 14 2014 | 6:03am ET

Peer-to-peer lending was invented with the individual investor in mind. But despite...

 

Sponsored Content

    For Hedge Funds, Mastering Data Is Key To Success

    Nov 4 2014 | 9:45am ET

    Data management is important to every business, but for hedge funds, it is critical. FINalternatives recently asked Peter Sanchez, CEO of Northern Trust Hedge Fund Services, how fund managers can deal with the demands of managing data while at the same time remain transparent and abide by operational best practices. Read more…

Editor's Note

    Guidelines for Guest Articles

    Oct 22 2014 | 9:46am ET

    We are always looking for guest articles from hedge fund managers and buy-side firms.

    If you are interested in submitting a contributed piece for possible publication on FINalternatives, please take a look at the specs. Read more…

 

Futures Magazine

November 2014 Cover

Building a better market

Reg NMS created a huge bifurcation in equity markets and while much of what has followed has been positive, in terms of lower fees and greater liquidity, many traders would like to see the market come...

The Alpha Pages

TAP July/August 2014 Cover

The Alpha Pages Interview: Senator Rand Paul

Senator Paul sat down in the debut series of the Alpha Pages Interview to discuss the broken tax code, regulation surrounding Bitcoin, and his plans for the 2016 Presidential election.